TNF是表观遗传预置的人破骨细胞前体稳态调节因子
该研究探讨TNF与RANK-L在人外周血不同前破骨细胞群体分化中的相互作用。发现TNF通过TNFR1-IKKβ通路诱导CD14+单核细胞RANK启动子表观遗传修饰,抑制破骨细胞生成而促巨噬细胞发育;但CD14-CD16-CD11c+髓系前破骨细胞群体不受此负调控。部分RA患者CD14+单核细胞表观遗传状态改变,导致TNF介导的破骨细胞稳态失调。
要点
- TNF经TNFR1-IKKβ通路表观调控CD14+单核细胞RANK启动子,抑制破骨细胞生成。
- CD14-CD16-CD11c+髓系前破骨细胞群体表观预置,不受TNF负调控。
- 部分RA患者CD14+单核细胞表观遗传改变,TNF介导的破骨细胞稳态失调。
核心结论
- TNF是CD14+单核细胞向破骨细胞分化的稳态调节因子,通过表观遗传机制抑制破骨细胞生成。
- 发现一群新型人循环非单核细胞来源破骨细胞前体,表观预置使其忽略TNF信号。
- 部分RA患者CD14+单核细胞表观遗传状态改变,导致TNF介导的破骨细胞稳态失调。
研究设计与样本
- 研究采用流式细胞分选与分析评估人外周血髓系群体向破骨细胞分化的潜能。
- 结合转录组、表观遗传分析、受体表达及抑制剂实验解析RANK-L与TNF信号层级。
主要发现
- TNF抑制CD14+单核细胞破骨细胞生成,促使其向巨噬细胞发育。
- CD14-CD16-CD11c+髓系前破骨细胞群体不受TNF负调控。
- 健康CD14+单核细胞中TNF经TNFR1-IKKβ依赖通路驱动RANK启动子表观修饰并阻断破骨细胞生成。
- 部分RA患者CD14+单核细胞表观状态改变,导致TNF介导的破骨细胞稳态失调。
临床怎么用
- 提示TNF对破骨细胞生成并非单纯促进,对CD14+单核细胞来源破骨细胞实为稳态抑制。
- RA中CD14+单核细胞表观预置异常可能是TNF通路失效的病理后果,需关注前破骨细胞异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Circulating myeloid precursors are responsible for post-natal osteoclast (OC) differentiation and skeletal health, although the exact human precursors have not been defined. Enhanced osteoclastogenesis contributes to joint destruction in rheumatoid arthritis (RA) and tumour necrosis factor (TNF) is a well-known pro-osteoclastogenic factor. Herein, we investigated the interplay between receptor activator of nuclear factor kappa-Β ligand (RANK-L), indispensable for fusion of myeloid precursors and the normal development of OCs, and TNF in directing the differentiation of diverse pre-OC populations derived from human peripheral blood. METHODS: Flow cytometric cell sorting and analysis was used to assess the potential of myeloid populations to differentiate into OCs. Transcriptomic, epigenetic analysis, receptor expression and inhibitor experiments were used to unravel RANK-L and TNF signalling hierarchy. RESULTS: TNF can act as a critical homoeostatic regulator of CD14+ monocyte (MO) differentiation into OCs by inhibiting osteoclastogenesis to favour macrophage development. In contrast, a distinct previously unidentified CD14-CD16-CD11c+ myeloid pre-OC population was exempt from this negative regulation. In healthy CD14+ MOs, TNF drove epigenetic modification of the RANK promoter via a TNFR1-IKKβ-dependent pathway and halted osteoclastogenesis. In a subset of patients with RA, CD14+ MOs exhibited an altered epigenetic state that resulted in dysregulated TNF-mediated OC homoeostasis. CONCLUSIONS: These findings fundamentally re-define the relationship between RANK-L and TNF. Moreover, they have identified a novel pool of human circulating non-MO OC precursors that unlike MOs are epigenetically preconditioned to ignore TNF-mediated signalling. In RA, this epigenetic preconditioning occurs in the MO compartment providing a pathological consequence of failure of this pathway.
引用
- Ansalone C, Cole J, Chilaka S, et al. TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursors. Ann Rheum Dis. 2021. PMID: 33692019. doi:10.1136/annrheumdis-2020-219262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。